Lattulosio Abc (Lactulose)

Lactulose is a synthetic disaccharide that is not absorbed in the small intestine. It reaches the colon where it draws water into the lumen, softening stool, and is fermented by bacteria into short‑chain fatty acids. This acidifies the colon, converting ammonia to ammonium, which reduces systemic absorption of ammonia.

The appropriate dose of Lattulosio Abc is determined by the prescribing healthcare professional based on the patient’s condition, severity, and response to therapy. Dosage may be adjusted over time, and patients should follow the specific instructions provided by their prescriber.

Safety data for lactulose in pregnancy and lactation are limited. The prescriber will weigh potential benefits against possible risks before recommending use. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss their situation with a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Lactulose is an osmotic laxative, differing from stimulant laxatives that increase intestinal motility. Its dual action—softening stool and lowering colonic ammonia—makes it uniquely suited for both constipation and hepatic encephalopathy, whereas many other laxatives address only bowel movement frequency.

Lattulosio Abc should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Lattulosio Abc is taken orally, usually as a liquid solution or syrup. It can be measured with a calibrated dosing device and consumed directly or mixed with a small amount of water or juice, as directed by the prescribing clinician.

Serious risks include severe electrolyte imbalance, dehydration, and rare allergic reactions such as rash or difficulty breathing. Patients experiencing persistent diarrhea, extreme weakness, or signs of an allergic response should seek medical attention promptly.

Lactulose is contraindicated in individuals with known intestinal obstruction, perforation, or severe inflammatory bowel disease. Patients with hypersensitivity to lactulose or any component of the formulation should also avoid its use.